, Tracking Stock Market Picks
Enter Symbol:
Sciclone Pharmaceuticals, Inc. (SCLN) [hlAlert]

up 30.75 %

Sciclone Pharmaceuticals, Inc. (SCLN) rated Buy with price target $8 by Aegis Capital

Posted on: Tuesday,  Nov 12, 2013  11:25 AM ET by Aegis Capital

Aegis Capital rated Buy Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) on 11/12/2013. Previously Aegis Capital rated Buy Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) on
07/16/2013., when the stock price was $5.95. Since then, Sciclone Pharmaceuticals, Inc. has gained 30.76% as of 01/05/2016's recent price of $7.78.
If you would have followed the previous Aegis Capital's recommendation on SCLN, you would have gained 30.75% of your investment in 903 days.

Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2013 11:25 AM Buy
4.69 8.00
as of 12/13/2013
1 Week up  2.59 %
1 Month up  3.71 %
3 Months down  -9.00 %
1 YTD up  1.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/16/2013 9:25 AM Buy
5.95 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy